Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Neuro-Oncology

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/neuonc/now037PMID 26995790PMCID PMC4799693
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice

  2015cited by this paper
• Macitentan: A Review of Its Use in Patients with Pulmonary Arterial Hypertension

  2014cited by this paper
• Current approaches to the treatment of metastatic brain tumours

  2014cited by this paper
• A randomized trial of bevacizumab for newly diagnosed glioblastoma.

  2014cited by this paper
• Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells.

  2014influential reference
• Therapy-resistant tumor microvascular endothelial cells contribute to treatment failure in glioblastoma multiforme

  2013cited by this paper
• Endothelin 1 in cancer: biological implications and therapeutic opportunities

  2013cited by this paper
• Perceptions and Experiences of Research Participants on Gender-Based Violence Community Based Survey: Implications for Ethical Guidelines

  2012cited by this paper
• Sunitinib-Induced Systemic Vasoconstriction in Swine Is Endothelin Mediated and Does Not Involve Nitric Oxide or Oxidative Stress

  2012cited by this paper
• Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.

  2012cited by this paper
• Slow Receptor Dissociation Kinetics Differentiate Macitentan from Other Endothelin Receptor Antagonists in Pulmonary Arterial Smooth Muscle Cells

  2012cited by this paper
• FOXO1 mediates the autocrine effect of endothelin-1 on endothelial cell survival.

  2012cited by this paper
• Autocrine Endothelin-3/Endothelin Receptor B Signaling Maintains Cellular and Molecular Properties of Glioblastoma Stem Cells

  2011cited by this paper
• Brain metastases as preventive and therapeutic targets

  2011cited by this paper
• The Vascular Endothelial Growth Factor Receptor Inhibitor Sunitinib Causes a Preeclampsia-Like Syndrome With Activation of the Endothelin System

  2011cited by this paper
• Preclinical approaches to study the biology and treatment of brain metastases.

  2011cited by this paper
• Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer.

  2011cited by this paper
• Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice

  2010cited by this paper
• Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer

  2010cited by this paper
• Real-time imaging reveals the single steps of brain metastasis formation

  2010cited by this paper
• Abstract 3428: Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy

  2010cited by this paper
• Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.

  2010cited by this paper
• Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis.

  2010cited by this paper
• Generation of an immortalized astrocyte cell line from H-2Kb-tsA58 mice to study the role of astrocytes in brain metastasis.

  2009cited by this paper
• The Vascular Basement Membrane as “Soil” in Brain Metastasis

  2009cited by this paper
• Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

  2008cited by this paper
• Phase I safety study of escalating doses of atrasentan in adults with recurrent malignant glioma.

  2008cited by this paper
• The Blood-Brain Barrier and Cancer: Transporters, Treatment, and Trojan Horses

  2007cited by this paper
• Brain metastases: epidemiology and pathophysiology.

  2007cited by this paper
• ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo

  2007cited by this paper
• A perivascular niche for brain tumor stem cells.

  2007cited by this paper
• Multidisciplinary management of brain metastases.

  2007cited by this paper
• Targeting receptor tyrosine kinase on lymphatic endothelial cells for the therapy of colon cancer lymph node metastasis.

  2006cited by this paper
• Increased incidence of brain metastases in cutaneous head and neck melanoma*

  2005cited by this paper
• Brain metastases: epidemiology and pathophysiology

  2005cited by this paper
• Expression of endothelin-1 is related to poor prognosis in non-small cell lung carcinoma.

  2005cited by this paper
• Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer

  2004cited by this paper
• Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer

  2004cited by this paper
• Expression of Endothelin-A-Receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer

  2004cited by this paper
• Expression of endothelin-1, endothelin-A, and endothelin-B receptor in human breast cancer and correlation with long-term follow-up.

  2003cited by this paper
• Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis.

  2003cited by this paper
• Brain metastases.

  2003cited by this paper
• Endothelin system: the double-edged sword in health and disease.

  2001cited by this paper
• Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells.

  2000cited by this paper
• Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells.

  1997cited by this paper
• Reactions of astrocytes and microglial cells around hematogenous metastases of the human brain. Expression of endothelin-like immunoreactivity in reactive astrocytes and activation of microglial cells.

  1995cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• Brain metastases.

  1991cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• Radation therapy for brain metastases

  1980cited by this paper
• Radiation therapy for brain metastases.

  1980cited by this paper
• Vascular Health and Risk Management Dovepress Macitentan for the Treatment of Pulmonary Arterial Hypertension the Endothelins and the Endothelin Receptors

  year unknowncited by this paper

• Astrocyte plasticity shapes brain metastasis progression through tumor-astrocyte crosstalk

  2025cites this paper
• Astrocyte reprogramming drives tumor progression and chemotherapy resistance in agent-based models of breast cancer brain metastases

  2025cites this paper
• The Involvement of the Peptidergic Systems in Breast Cancer Development

  2025cites this paper
• Brain microenvironment orchestrates highly aggressive tumor variants: current trends and therapeutic approaches

  2025cites this paper
• Astrocyte involvement in brain metastasis: from biological mechanisms to therapeutic strategies

  2025cites this paper
• Astrocyte Reprogramming Drives Tumor Progression and Chemotherapy Resistance in Agent-Based Models of Breast Cancer Brain Metastases

  2025cites this paper
• Identification of New Chemoresistance-Associated Genes in Triple-Negative Breast Cancer by Single-Cell Transcriptomic Analysis

  2024cites this paper
• Analysis of neuroglia and immune cells in the tumor microenvironment of breast cancer brain metastasis

  2024cites this paper
• A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer

  2024cites this paper
• The progress of microenvironment-targeted therapies in brain metastases

  2023cites this paper
• The Role of Endothelin Axis in Cancer Treatment and Its Position in Therapeutic Strategies

  2023cites this paper
• Macitentan improves antitumor immune responses by inhibiting the secretion of tumor-derived extracellular vesicle PD-L1

  2022cites this paper
• A Double Regression Method for Graphical Modeling of High-dimensional Nonlinear and Non-Gaussian Data.

  2022cites this paper
• The EDN1/EDNRA/β-arrestin axis promotes colorectal cancer progression by regulating STAT3 phosphorylation

  2022cites this paper
• Error‐controlled feature selection for ultrahigh‐dimensional and highly correlated feature space using deep learning

  2022cites this paper
• Glutamatergic Neurons in the Amygdala Are Involved in Paclitaxel-Induced Pain and Anxiety

  2022cites this paper
• Tumor Immune Microenvironment of Brain Metastases: Toward Unlocking Antitumor Immunity.

  2022cites this paper
• Circulating tumor DNA detection in peripheral blood in postoperative efficacy evaluation and recurrence risk prediction of lung cancer.

  2022cites this paper
• Brain Metastases and Microenvironment.

  2021cites this paper
• Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design

  2021cites this paper
• YAP and endothelin-1 signaling: an emerging alliance in cancer

  2021cites this paper
• Connexins in Lung Cancer and Brain Metastasis

  2020cites this paper
• Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy

  2020cites this paper
• Understanding Breast cancer: from conventional therapies to repurposed drugs.

  2020cites this paper
• Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.

  2020cites this paper
• Endothelin-1 axis fosters YAP-induced chemotherapy escape in ovarian cancer.

  2020cites this paper
• Targeting the Tumor Microenvironment in Brain Metastasis.

  2020cites this paper
• Markov Neighborhood Regression for High-Dimensional Inference

  2020cites this paper
• Nonlinear Variable Selection via Deep Neural Networks

  2020cites this paper
• Targeting the endothelin axis as a therapeutic strategy for oral cancer metastasis and pain

  2020cites this paper
• Brain metastasis models: What should we aim to achieve better treatments?

  2020cites this paper
• A Blazing Landscape: Neuroinflammation Shapes Brain Metastasis.

  2019cites this paper
• Transcriptomic Hallmarks of Tumor Plasticity and Stromal Interactions in Brain Metastasis

  2019cites this paper
• Endothelin: 30 Years From Discovery to Therapy.

  2019cites this paper
• Drug sensitivity prediction with high-dimensional mixture regression

  2019cites this paper
• Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer

  2019cites this paper
• Preclinical Models of Brain Metastases

  2019cites this paper
• Identification of Transcriptional Markers and microRNA–mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma

  2019cites this paper
• Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach

  2019cites this paper
• The evolving role of trastuzumab emtansine (T-DM1) in HER2-positive breast cancer with brain metastases.

  2019cites this paper
• β-arrestin1/YAP/mutant p53 complexes orchestrate the endothelin A receptor signaling in high-grade serous ovarian cancer

  2019cites this paper
• GPCR Modulation in Breast Cancer

  2018cites this paper
• Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis.

  2018cites this paper
• Targeting the perivascular niche in brain tumors

  2018cites this paper
• Bayesian Neural Networks for Selection of Drug Sensitive Genes

  2018cites this paper
• Reactive Astrocytes in Brain Metastasis

  2017cites this paper
• The Microenvironmental Landscape of Brain Tumors.

  2017cites this paper
• Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer

  2017cites this paper
• Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancer

  2017cites this paper
• Brain metastasis: Unique challenges and open opportunities.

  2017cites this paper
• Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts

  2017cites this paper
• Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia

  2017cites this paper
• Melanoma central nervous system metastases: current approaches, challenges, and opportunities

  2016cites this paper
• Exploiting drug repositioning and the brain microenvironment to treat brain metastases.

  2016influential citation
• Orchestration of the crosstalk between astrocytes and cancer cells affects the treatment and prognosis of lung cancer sufferers with brain metastasis.

  2016influential citation
• In Vivo Kinome Screen Reveals Non-canonical CDK-driven Metabolic Adaptation in Brain Metastasis

  2016cites this paper
• Closing the gap: astrocytes and brain metastasis

  2016cites this paper